...
首页> 外文期刊>Current pharmaceutical design >Polymeric Based Therapeutic Delivery Systems Prepared Using Electrohydrodynamic Processes
【24h】

Polymeric Based Therapeutic Delivery Systems Prepared Using Electrohydrodynamic Processes

机译:使用电动流体动力学方法制备的基于聚合物的治疗性给药系统

获取原文
获取原文并翻译 | 示例
           

摘要

The development of therapeutic dosage (e.g. pharmaceutical) systems is an ongoing process which, in recent times has incorporated several emerging disciplines and themes at timely intervals. While the concepts surrounding dosage forms have developed and evolved, many polymeric excipients remain as the preferred choice of materials over existing counterparts, serving functions as matrix materials, coatings and providing other specific functional properties (e.g. adhesion, controlled release and mechanical properties). There have been, however, developments in the deployment of synthetic polymeric materials (e.g. polycaprolactone, poly lactic co-glycolic acid) when compared to naturally occurring materials (e.g. lactose, gelatin). Advances in pharmaceutical process technologies have also provided novel engineering platforms to develop a host of exciting structure based materials ranging from the nanometer to the macro scales. Some of these structure enabling technologies include spray drying, super critical processing, microfluidics and even wet chemical methods. More recently electrohydrodynamic (EHDA) engineering methods have emerged as robust technologies offering potential to fabricate a plethora of generic structures (e.g. particles, fibres, bubbles and pre-determined patterns) on a broad scale range. This review focuses on key developments using various EHDA technologies for the pharmaceutical and biomaterial remits when selecting synthetic and/or naturally occurring polymers as pharmaceutical (and therapeutic) excipients. In addition, the underlying EHDA process principles are discussed along with key parameters and variables (both materials and engineering). EHDA technologies are operational at ambient conditions and recent developments have also demonstrated their viability for large scale production. These are promising technologies which have potential in established (e.g. films, dressings and microparticles) and emerging scientific themes (e.g. nanomedicines and tissue engineering).
机译:治疗剂量(例如药物)系统的开发是一个持续的过程,最近它已及时地并入了几个新兴学科和主题。尽管围绕剂型的概念已经发展和演变,但是许多聚合物赋形剂仍然是现有的材料的首选材料,它们起基质材料,包衣的作用,并提供其他特定的功能特性(例如粘附力,控释和机械性能)。然而,与天然材料(例如乳糖,明胶)相比,合成聚合物材料(例如聚己内酯,聚乳酸共乙醇酸)的展开已有发展。制药工艺技术的进步也提供了新颖的工程平台,以开发各种令人兴奋的基于结构的材料,范围从纳米到宏观。其中一些使能结构的技术包括喷雾干燥,超临界工艺,微流体技术,甚至是湿化学方法。最近,电液动力学(EHDA)工程方法作为一种强大的技术而出现,它们具有潜力在大范围的范围内制造大量的通用结构(例如,颗粒,纤维,气泡和预定图案)。当选择合成和/或天然存在的聚合物作为药物(和治疗性)赋形剂时,本文将重点介绍使用各种EHDA技术用于药物和生物材料药典的关键发展。此外,还讨论了基本的EHDA过程原理以及关键参数和变量(材料和工程)。 EHDA技术可在环境条件下运行,最近的发展也证明了其在大规模生产中的可行性。这些是有前途的技术,在已确立的(例如薄膜,敷料和微粒)和新兴的科学主题(例如纳米药物和组织工程)中具有潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号